This year's conference continues to facilitate a consistent approach to managed entry of new drugs in cancer treatment, and to promote the cost effective and equitable provision of all medicines used in cancer, in London. Key topics include: * GP commissioning * Cancer care in the new commissioning environment * QIPP and the cancer agenda * Update on the Cancer Drugs Fund * Chemotherapy in the community This conference is aimed at directors of commissioning of primary care organisations and their teams, clinical and management directors of UK cancer networks, LCNDG members, representatives of UK technology appraisal groups, senior officials from SHAs and other healthcare professionals with an interest in planning and commissioning cancer services. Please be advised that members of the pharmaceutical industry may only register if their company is sponsoring the meeting.